ENHANCEMENT OF IMMUNOSUPPRESSION BY SUBSTITUTION OF FISH OIL FOR OLIVE OIL AS A VEHICLE FOR CYCLOSPORINE
- 1 July 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 48 (1) , 98-101
- https://doi.org/10.1097/00007890-198907000-00023
Abstract
As previously reported, acute cyclosporine-induced nephrotoxicity is characterized by a decline in glomerular filtration rate and a selective intrarenal production of the vasconstrictor thromboxane (TxA2), but not vasodilator prostaglandin E2 (PGE2), or prostacyclin (PGI2), cyclooxygenase metabolites. Fish oils (FO), that are rich in n-3 polyunsaturated fatty acids have a high affinity for cyclooxygenase but serve as poor substrate inhibit TxA2 synthesis. We have shown that when FO replaces olive oil (OO) as the vehicle for CsA, CsA-induce nephrotoxicity and increased TxA2 synthesis are obviated in rodent models. In this study, we demonstrate that the FO vehicle for CsA does not compromise CsA''s immunosuppressive properties as deduced from studies of a delayed-type hypersensitivity (DTH) model in BALB/c mice and in a rat heart transplant model. In fact, concurrent FO adminstration with CsA actually enhances immunosuppression. A dose of CsA incapable of blunting DTH when injected in OO was suppressive when given in FO. Administration of as little as 0.05 ml of FO vehicle potentiated the suppressive action of CsA. In addition, nonconcurrent dietary supplementation of FO in animals receiving CsA caused an increase in the immumosuppressive action of CsA in DTH. FO alone reduced DTH as compared with OO, but was far less effective than CsA plus FO. Furthermore, doses of CsA (5 mg/kg/day or 1.5 mmg/kg/day), which are subtherapeutic when administered with OO, prolonged engraftment of Lewis recipients of Lewis .times. Brown-Norway F1 hearts when CsA was solubilized with FO. These studies indicate that concurrent administration of CsA and FO potentiates the activity of CsA and thus increases its therapeutic index. Thus, CsA plus FO is potentially a safe, potent antirejection therapy worthy of clinical testing, especially insofar as FO prevents CsA-induced acute nephrotoxicity in the rodent.This publication has 10 references indexed in Scilit:
- Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.The Journal of Immunology, 1988
- SELECTIVE ENHANCEMENT OF THROMBOXANE IN MACROPHAGES AND KIDNEYS IN CYCLOSPORINE-INDUCED NEPHROTOXICITYTransplantation, 1988
- A fish oil diet retards experimental amyloidosis, modulates lymphocyte function, and decreases macrophage arachidonate metabolism in mice.The Journal of Immunology, 1987
- Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice.The Journal of Experimental Medicine, 1985
- A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice.The Journal of Immunology, 1985
- Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.Proceedings of the National Academy of Sciences, 1984
- CYTOKINES AND THE CHRONIC INFLAMMATION OF RHEUMATIC DISEASE .1. THE PRESENCE OF INTERLEUKIN-1 IN SYNOVIAL-FLUIDS1984
- Isolation of an interleukin‐1‐like factor from human joint effusionsArthritis & Rheumatism, 1983
- Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis.Proceedings of the National Academy of Sciences, 1983
- Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice.Journal of Clinical Investigation, 1981